These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 212346)

  • 21. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
    Rioux L; Gaudin DP; Gagnon C; Di Paolo T; Bédard PJ
    Neuroscience; 1991; 44(1):75-83. PubMed ID: 1770999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of nigral projections to the thalamus in drug-induced circling behaviour in the rat.
    Reavill C; Jenner P; Leigh N; Marsden CD
    Life Sci; 1981 Mar; 28(13):1457-66. PubMed ID: 7017327
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.
    Metz GA; Whishaw IQ
    Neuroscience; 2002; 111(2):325-36. PubMed ID: 11983318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced dopamine metabolism in accumbens leads to motor activity and concurrently to increased output from nondopamine neurons in ventral tegmental area and substantia nigra.
    Olds ME
    Physiol Behav; 1992 Jan; 51(1):39-50. PubMed ID: 1311110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposite locomotor asymmetries elicited from the medial and lateral SN by modulation of SN DA receptors.
    Vaccarino FJ; Franklin KB
    Pharmacol Biochem Behav; 1984 Jul; 21(1):73-7. PubMed ID: 6540452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
    Reavill C; Leigh N; Jenner P; Marsden CD
    Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic mechanisms and stereotyped behaviour in birds.
    Nistico' G; Stephenson JD
    Pharmacol Res Commun; 1979 Jul; 11(7):555-70. PubMed ID: 116248
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of dopaminergic agents on monoamine levels and motor behaviour in planaria.
    Algeri S; Carolei A; Ferretti P; Gallone C; Palladini G; Venturini G
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 74(1):27-9. PubMed ID: 6132769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circling behaviour induced by apomorphine after lesions of the habenula.
    Wickens AP; Thornton EW
    Exp Brain Res; 1996 Apr; 109(1):17-21. PubMed ID: 8740204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and behavioural studies on the interference between catecholaminergic and serotonergic central systems.
    Allikmets LH; Zharkovsky AM
    Ann Ist Super Sanita; 1978; 14(1):63-70. PubMed ID: 40501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG; Glick S; Mellentin J
    Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 34. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative involvement of dopamine and noradrenaline in rate-free self-stimulation in substania nigra, lateral hypothalamus, and mesencephalic central gray.
    Liebman JM; Butcher LL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):167-94. PubMed ID: 4152814
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function.
    Hirsch SR; Richardson-Andrews R; Costall B; Kelly ME; de Belleroche J; Naylor RJ
    Psychopharmacology (Berl); 1987; 93(1):101-4. PubMed ID: 2819921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine dependence and dopaminergic activity: tests of circling responses in rats with unilateral nigral lesions.
    Halliwell JV; Kumar R
    Br J Pharmacol; 1980 Dec; 70(4):545-54. PubMed ID: 6258680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
    Koller WC; Herbster G
    Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.